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The use of oral fluid as a biologicalmatrix tomonitor the use of drugs of abuse is a global trend because it presents several advantages
and good correlation to the blood level.Thus, the presentwork aimed to develop and validate an analyticalmethod for quantification
and detection of solvents used as inhalants of abuse in oral fluid (OF), using Quantisal as collector device by headspace and gas
chromatography coupled with amass detector (HS-GC/MS). Chromatographic separation was performed with a ZB-BAC1 column
and the total time of analysis was 11.8min. The method showed good linearity (correlation coefficient higher than 0.99 for all
solvents). The limits of detection ranged from 0.05 to 5mg/L, while the lower limits of quantification ranged from 2.5 to 12.5mg/L.
Accuracy, precision, matrix effect, and residual effect presented satisfactory results, meeting the criteria accepted for the validation
of bioanalytical methods. The method showed good selectivity considering that, for solvents coeluting at the same retention time,
resolution was performed by the mass detector. The method developed proved to be adequate when applied in OF samples from
users of drugs and may be used to monitor the abuse of inhalants in routine forensic analyses.
1. Introduction
The abuse of inhalants, also known as abuse of volatile
substances or abuse of solvents [1, 2], is a global issue with
major consequences for users, their families, and society. It
is defined as the intentional inhalation of volatile substances,
aiming to reach an altered mental state [1–4]. This problem
has been neglected in researches on drug abuse and in
national and international drug policies [4].
Several commercial products may be used as inhalants,
such as glues, paints, varnishes, removers, sprays, nail pol-
ishers, and fuels [4, 5]. These products may be classified
according to their chemical structure, commercial use, or
pharmacological profile [5]. Products containing inhalants
are usually a mix of two or more solvents. Toluene is present
in many products for household and industrial use and is
most often used as a solvent inhalant abuse worldwide [5–
7]. In Brazil, the main products used with the presence of
solvents are lança-perfume (chloroethane) and cheirinho-da-
loló—ahomemade version of lança-perfume containing amix
of diethyl ether, ethanol, and chloroform [6, 7]. Recently,
another formula based on Freon gases (gas based on
halogenated substances) has been intentionally used mainly
at electronic music parties, and it is called “success” and
“the drug of success.” Freon is a refrigerant gas based on
halogenated substances used in home appliances such as
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freezers and air conditioners [8, 9], and it has been applied
as raw material in the fabrication of inhalants of abuse.
Although data on inhalants are abundant in literature, there
is still little information on the abuse of Freon [9].
The abuse of these substances is a disseminated problem
among children, adolescents living in the streets [10, 11],
and rave partygoers because of its psychoactive effects [12].
Inhalants are featured as the fourth drug of abuse most used
in Brazil, after alcohol, marijuana, and tobacco [10–12]. As
for the United States, studies show that approximately 100
youngsters die per year due to cardiac arrest associated with
the use of inhalants [10–12].
Inhalants may be administered by several methods [2,
4]. Glues are usually placed in either plastic or paper bags
so their vapors are inhaled through the mouth and nose
(bagging); pieces of fabric may be soaked with solvents and
inhaled (huffing); theymay also be inhaled directly from their
recipients (sniffing) or by direct spraying in themouth or nose
(dusting) [2, 4, 13, 14].The higher inhalant concentrationmay
be achieved through bagging and huffing; therefore, these
methods of abuse are mostly preferred [2, 15].
The use of inhalants allows high concentrations to quickly
reach lungs and brain [16]. The toxic effects resulting from
inhalation are similar to the ones caused by ethanol; first,
the users feel euphoric and uninhibited followed by lethargy,
slurred speech, and other depressant effects of the central
nervous system (CNS) [16, 17]. High doses may cause convul-
sions, asphyxia, cardiac dysfunction, cessation of breathing,
coma, and death [16–18].
Considering the strong consumption of inhalant solvents,
it is important to define a laboratory parameter to assess
the acute exposure to these solvents. Therefore, gas chro-
matography coupled with mass detector (GC/MS) may be
considered the method of choice to identify and separate
solvents of abuse, mostly when associated with the headspace
(HS) sampling technique. AlthoughGC/MS is considered the
“gold standard” technique for unequivocal confirmation of
results and is present in forensic laboratories, most studies
found in literature use gas chromatography coupled with
flame ionization detector (GC/FID) [18–22].
Thus, the present work aims to develop and validate an
analytical method by HS-GC/MS for simultaneous detection
and quantification of solvents in oral fluid (OF). The OF bio-
logical matrix was chosen because it presents as an advantage
the possibility of a quick, noninvasive collection, under direct
supervision [23]. Although blood is the most used matrix to
assess the exposure to volatile compounds, the suggestion of
using OF as biological matrix to monitor the use of drugs of
abuse is a global trend because it presents good correlation
to blood level [23, 24], and it may be collected through
commercial devices [24]. Quantisal was the device chosen to
collect OF samples, for its best collection volume indicator
(1mL) and because it has already been validated by our
research group [24, 25]. After themethodwas validated, it was
applied in OF samples from 22 volunteers, men and women,
who were users of multiple drugs, and participants of the
Assistance Program forUsers of “ClubDrugs,” in partnership
with the Psychiatric Service of the Clinics Hospital of Porto
Alegre and the Center for Drugs and Alcohol Research
Table 1: Grouping of substances by working concentration range
(mg/L).
Analyte Working concentration range (mg/L) Code






(CPAD) of the Federal University of Rio Grande do Sul
(UFRGS), Brazil.
2. Materials and Methods
2.1. Reagents and Materials. Ethanol, diethyl ether, dichloro-
methane, chloroform, ethyl acetate, n-butanol, n-propanol,
toluene, xylene, and isopentanol (internal standard, IS) were
obtained fromTedia Company (Fairfield, OH,USA). An ana-
lytical standard FreonMix containing a mix of dichlorodiflu-
oromethane (Freon 12), 1,2-dichloro-1,1,2,2-tetrafluoroethane
(Freon 114), dichlorofluoromethane (Freon 21), chlorodifluo-
romethane (Freon 22), and trichlorofluoromethane (Freon 11)
in ethyl acetate solution was obtained from Sigma-Aldrich.
Quantisal OF collection devices, filters, and a preservative
buffer solutionwere obtained from Immunalysis Corporation
(Pomona, CA, USA). Each device contains a collector that
turns blue when about 1mL of OF is gathered and a plastic
tube for transportation with 3mL of preservative buffer,
resulting in a final sample volume of 4mL. Headspace vials
and aluminum screw caps with PTFE-silicone septa were
obtained from Agilent Technologies (Agilent J&W Scientific,
Folsom, CA, USA).
2.2. Biological Samples. OF samples free of volatile solvents
from six volunteers were used formethod validation. Samples
were stored in a freezer until the moment of analyses.
For the application of the method developed, OF samples
were collected from participating volunteers of an Assistance
Program toDrugsUsers.TheOF samples from the volunteers
were collected at the outpatient Psychiatric Service of the
Clinics Hospital of Porto Alegre. Ethical approval was given
by the Ethics Committee of the Clinics Hospital of Porto
Alegre.
2.3. Preparation of Working Solutions and Internal Standard.
The working solutions of ethanol, diethyl ether, dichloro-
methane, chloroform, ethyl acetate, and n-butanol were
prepared in methanol with a concentration of 2000mg/L.
Isopentanol (IS) was prepared with a concentration of
2000mg/L. After preparation, all solutions were stored in a
freezer until the moment of use.
2.4. Sample Preparation. The substances were grouped
according to the working concentration range (Table 1). To
build the calibration curve, proper dilutions were performed
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until reaching seven concentrations, which were added to
1mL of blank OF. The calibration curve of Group A was
built in the range of 50mg/L to 1000mg/L and for Group
B in the range of 10mg/L to 120mg/L. The LLOQ (lower
limit of quantification), LQC (low quality control), MQC
(medium quality control), HQC (high quality control), and
DQC (dilution quality control) were prepared in concentra-
tions of 50, 100, 500, 800, and 500mg/L, respectively, for
Group A, and 10, 20, 60, 100, and 50mg/L, respectively, for
Group B.
Final solutions were diluted with 3mL of Quantisal
preservative so to mimic the process using the Quantisal
collection device and then vortexed for 10 seconds. Next,
an aliquot of 1mL was removed and transferred to a 10mL
headspace vial. Ten 𝜇L of IS solution was added and the
vial was immediately sealed and placed in the vial rack
of the autosampler, so to be submitted to chromatographic
analysis.
2.5. Conditions ofHS-GC/MS. Analyseswere performedwith
a GC 5975C chromatograph coupled with a 7890A mass
detector (Agilent Technologies, CA, USA) and equipped
with HS automatic injector (CTC Analytics Combipal, Basel,
Switzerland). The column used for method validation was
the ZB-BAC1, Zebron (Phenomenex) (30m × 0.32mm ×
1.8 𝜇m) provided by Alcrom (São Paulo, Brazil); also aiming
to improve specificity and to compare the order of elu-
tion of analytes, a Carbowax column (30m × 0.25mm ×
0.25 𝜇m) was tested. Oven temperature was programed at
30∘C (2.5min) with ramp rate of 5∘C/min to 65∘C, followed
by a ramp rate of 60∘C/min to 200∘C, which was maintained
for 1min, with a total time of analysis of 11.8min. The
injector was maintained at 200∘C with split ratio of 25 : 1.
The temperatures of the transfer line (interface), source, and
quadrupole were maintained at 220∘C, 230∘C, and 150∘C,
respectively.Ultrapure heliumwas used as carrier gas at a flow
rate of 1.4mL/min.Themass detector systemwas operated in
electron impact ionization at 70 eV and in SIM (Single Ion
Monitoring) mode.The ions monitored for ethanol werem/z
45, 46, 31, and 29; for diethyl ether m/z 74, 59, 45, and 31; for
dichloromethane m/z 86, 84, 51, and 49; for chloroform m/z
119, 121, 83, and 47; for ethyl acetatem/z 88, 61, 45, and 43; for
butanolm/z 74, 56, 41, and 28; for isopentanol (IS)m/z 87, 70,
55, and 42. The ions underlined were used for quantification.
Solvent responsewas assessed by the ratio between peak areas
of the analyte and the IS.
Headspace was maintained at 85∘C with incubation time
of 5min. Experimental conditions of headspace time and
temperature were chosen based on previous studies per-
formed by our group [25, 26].
2.6. Method Validation. Validation was performed according
to recommendations of the USA Food andDrug Administra-
tion (FDA) [27] and the BrazilianHealth SurveillanceAgency
(ANVISA) [28]. The parameters assessed were selectivity,
matrix effect, residual effect, linearity, precision, accuracy,
limit of detection, limit of quantification, and stability [27,
28].
2.6.1. Selectivity. Selectivity was assessed through the analysis
of six OF samples from different individuals who were part of
the control group and the results were compared to samples of
the lower limit of quantification (LLOQ). Complementarily,
other solvents added to the sample were analyzed in order
to verify their potential interference on the analysis in the
retention times of analytes. The solvents tested were n-
propanol, isopropanol, toluene, xylene, and Freon Mix.
2.6.2. Residual Effect and Matrix Effect. In the assessment of
residual effect, a blank sample was previously analyzed and
two blank samples were analyzed after a sample of the upper
limit of quantification (ULOQ). Results were compared to the
responses obtained in the LLOQ, and results above 20% in
retention time (rt) of analytes and 5% in IS were not accepted.
Matrix effect was assessed through the analysis of three
high quality controls (HQC) and three low quality controls
(LQC) in matrix and in distilled water. Results were assessed
through the matrix effect (ME), and coefficient of variation
(CV%) among ME above 15% was not allowed:
ME
=
response of analyte in OF/response of IS in OF
response of analyte in solution/response of IS in solution
.
(1)
2.6.3. Linearity. The linearity of the concentration range
proposed was verified through the construction of three
calibration curves in three different days including seven
concentrations: Group A: 50, 75, 100, 250, 500, 750, and
1000mg/L and Group B: 10, 20, 40, 60, 80, 100, and 120mg/L.
These data allowed obtaining the equation of the straight
line through linear regression. The suitability of the adjusted
models was evaluated by residual analysis, and, for cases
where there was heterogeneity of variance, which leads to
obtain inconsistent estimates for the regression coefficients,
standard errors, we opted for the use of robust estimators
for the same. Data analysis was performed using statistical
software SAS, version 9.4.
2.6.4. Precision and Accuracy. Precision and accuracy were
run in three different days through the analysis of five
replicates of LLOQ, LQC, MQC, HQC, and DQC. Precision
was assessed through CV (%), and accuracy was assessed
through the relative standard deviation (RSD). Accuracy and
precision allowed values below 15%, except for the LLOQ,
which allowed values below or equal to 20%.
2.6.5. Limit of Detection and Limit of Quantification. The
LOQ was determined with precision values below 20% and
accuracy values within 80–120% through the analysis of five
samples in the concentrations of the LLOQ. The LOD was
estimated at a signal/noise ration of three.
2.6.6. Stability. Stability was assessed through the analysis
of three LQC and three HQC analyzed after 24 hours, 48
hours, and 10 days stored in freezer and after five freezing
and thawing cycles (24 h). The stability of IS and analytes in
solution was analyzed. For the study of stability, calibration













































































Figure 1: Chromatographic analysis of quantified solvents. (1)
Ethanol, (2) diethyl ether, (3) dichloromethane, (4) chloroform, (5)
ethyl acetate, (6) n-butanol, and (7) isopentanol/IS.
curves prepared in the day of analysis were used and the
results were assessed through the standard deviation of the
mean concentrations obtained in relation to the nominal
value, not allowing values above 15%.
3. Results and Discussion
3.1. Method Validation. The HS-GC/MS method was devel-
oped and validated for quantitative analysis of six solvents,
which presented proper resolution (Figure 1). Solvents were
identified through the retention time and their respective
mass spectra in which four ions were monitored for each
substance, considering these were the most abundant and
representative of each of the molecules (Figure 2).
In order to improve the specificity of the method, all
quantified and qualified solvents were injected into a second
column (Carbowax), in which polarity was different enough
to change retention times and order of elution of the solvents
studied; the results are described in Table 2. The use of
different columns represents one more analytical parameter
that aims to improve the reliability of the result obtained.
3.1.1. Selectivity. After analyzing six different OF samples,
there were no peaks close to the retention times of analytes.
Moreover, selectivity was assessed by analyzing other volatile
substances that may be present in products used as inhalants
of abuse or used in their adulteration, such as paints, resins,
and fuels. Additions to the sample were n-propanol, toluene,
and xylene, which coeluted in different retention times from
the quantified analytes and the IS (Figure 3).
When adding chloroethane, which is themain compound
of lança-perfume, one of the most popular inhalants of abuse
in Brazil [7], it coeluted at the same retention time as ethanol,
considering that identification had to be performed through
the mass spectrum of these substances, in which spectra
were different enough to allow unequivocal identification
of each one (Figure 4). Identification and quantification of
ethanol and chloroethane by GC/MS excluded the possibility
of incorrect results. The analysis by GC/MS allows the
identification and quantification of analytes [29], and it is
advantageous in comparison to GC/FID, which is mostly
studied for the analysis of inhalants. The analysis by GC/FID
does not provide structural information of molecules, which
prevents confirming the identity of these molecules. The
analysis of both solvents becomes imperative, considering
that ethanol is not only part of the composition of inhalants
of abuse but the main component of alcoholic beverages,
providing that the use of inhalants and the consumption of
alcoholic beverages may occur simultaneously.
Additionally, a Freon Mix standard was injected, con-
taining a mix of dichlorodifluoromethane (Freon 12), 1,2-
dichloro-1,1,2,2-tetrafluoroethane (Freon 114), dichlorofluo-
romethane (Freon 21), chlorodifluoromethane (Freon 22),
and trichlorofluoromethane (Freon 11) in ethyl acetate solu-
tion (Figure 5). It was possible to observe that dichloroflu-
oromethane (Freon 21) coeluted at the same retention time
as ethanol, and identification, in this case, should be done by
the analysis of mass spectrum of each substance presenting
distinct ions.
3.1.2. Residual Effect and Matrix Effect. The response of
interference peaks in retention times of analytes on blank
samples injected after the upper limit of quantification
(ULOQ) was below 5%. The matrix effect was also within
the limits accepted, presenting coefficients of variation below
15%, as recommended by the guidelines [27, 28].
3.1.3. Linearity. In the concentration range studies and for
all compounds, the analytical response was linear with
coefficients of determination (𝑅2) higher than 0.99, showing
a proportional increase of the peak area ratio in relation to
analyte concentration, and a correct adjustment to the linear
model was achieved with high significance of regressions for
all solvents analyzed (Table 3). Furthermore, the quadratic
component was tested in the model and was not significant
for all solvents.
3.1.4. Limit of Detection and Limit of Quantification. The
lower limit of quantification of the method proposed was
12.5mg/L for ethanol and butanol and 2.5mg/L for diethyl
ether, dichloromethane, chloroform, and ethyl acetate. The
limit of detection estimated by signal/noise ratio of approx-
imately three times was 5mg/L for ethanol and butanol,
0.1mg/L for diethyl ether and ethyl acetate, and 0.05mg/L
for dichloromethane and chloroform. These results show the
increase in sensitivity of GC/MS when compared to other
methods found in literature using GC/FID [22].
3.1.5. Precision and Accuracy. The tests for precision and
accuracy, inter- and intraday, presented coefficients of vari-
ation (CV) and relative standard deviation (RSD) below 20%
for LLOQ and below 15% for the remaining controls, meeting
the criteria for validation of bioanalytical methods applied
(Table 4).

































































































































Figure 2: Mass spectra ethanol, diethyl ether, dichloromethane, chloroform, ethyl acetate, and n-butanol with their proposed fragmentation.
Table 2: Retention time (min) of the solvents tested in both columns.
Analyte Retention time (min)
ZB-BAC1 column (Phenomenex) Analyte Carbowax column (Agilent)
Ethanol 2.005 Diethyl ether 1.459
Diethyl ether 2.691 Ethyl acetate 2.695
Dichloromethane 2.952 Dichloromethane 3.109
n-Propanol 3.465 Ethanol 3.482
Chloroform 4.864 Chloroform 4.624
Ethyl acetate 5.367 Toluene 5.026
n-Butanol 6.293 n-Propanol 5.469
Isopentanol 8.774 p-Xylene 7.008
Toluene 9.587 m-Xylene 7.212
p-Xylene 10.460 o-Xylene 7.398
m-Xylene 10.571 n-Butanol 8.092
o-Xylene 10.726 Isopentanol 9.707
3.1.6. Stability. The results obtained in the stability study for
the period of 24 h, 48 h, and 10 days in freezer (−1 to −8∘C)
showed deviation below 15% in relation to the nominal con-
centration for ethanol and butanol. Also for both substances,
deviation was below 15% after performing cycles of freezing
and thawing. Ethyl acetate was stable for a period of 24 h
in freezer, while diethyl ether, dichloromethane, and chlo-
roform were not stable with range above 15%. Diethyl ether,
dichloromethane, chloroform, and ethyl acetate showed devi-
ations above 15% after 48 h and 10 days in freezer and after
cycles of freezing and thawing.The stability of analytes and IS
in solution for 20 h in freezer was attested. Considering that


















































































Figure 3: Chromatogram of simultaneous analysis of ten organic
solvents for the assessment of selectivity. (1) Ethanol, (2) diethyl
ether, (3) dichloromethane, (4) n-propanol, (5) chloroform, (6) ethyl
acetate, (7) n-butanol, (8) isopentanol (IS), (9) toluene, (10) p-
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Figure 4: Chromatogram of a simultaneous analysis of ethanol and
chloroethane and their mass spectra.
stability test aims to establish ideal conditions of storage and
transportation of samples, and regarding volatile substances,
it is recommended that they are frozen immediately after
collection and analyzed in a period shorter than 24 h to avoid
evaporation of solvents in analysis.
3.2. Application of the Method Developed. Themethod devel-
oped was applied in participating volunteers from an Assis-
tance Program to Drugs Users as part of a project developed
by the Center for Drug and Alcohol Research of the Federal
University of Rio Grande do Sul, Brazil.
The collection of OF was performed through Quantisal





































































Figure 5: Chromatogram of the analysis of chlorofluorocar-
bons (Freon Mix). (1) Chlorodifluoromethane, (2) dichlorodiflu-
oromethane, (3) 1,2-dichlorotetrafluoroethane, (4) dichlorofluo-
romethane, (5) trichlorofluoromethane, and (6) ethyl acetate.
Table 3: Results obtained from linear regression.
Analytes Equationa 𝑅2b 𝑃c
Ethanol 𝑦 = 1.2667𝑥 + 0.0261 0.998 <0.0001
Diethyl ether 𝑦 = 0.0941𝑥 + 0.0014 0.996 <0.0001
Dichloromethane 𝑦 = 0.0657𝑥 + 0.0005 0.996 <0.0001
Chloroform 𝑦 = 0.0313𝑥 + 0.001 0.996 <0.0001
Ethyl acetate 𝑦 = 0.0821𝑥 + 0.002 0.996 <0.0001
n-Butanol 𝑦 = 0.515𝑥 + 0.0322 0.995 <0.0001
aEquation obtained from calibration curve. b𝑅2 obtained from calibration
curve. c𝑡-test for linear regression coefficient.
to participate in the study and signed the consent term. After
collection, the samples were immediately frozen until the
moment of analysis by HS-GC/MS.
From the twenty-two samples collected, thirteen showed
the presence of peaks of ethanol. For the remaining sol-
vents, all samples were negative. The results for ethanol
quantification in OF ranged from 50mg/L to 60mg/L; such
concentrations were very close to the limit of quantification.
This can be explained by the fact that volunteers selected are
participants of an Assistance Program to Drugs, a different
situation from the target public. By ethic reasons, thismethod
could not be applied in specific places where the use of these
substances is more common, as electronic music parties.
Moreover, the stability of these solvents is shorter than
ethanol mainly because of the high level of volatility which
contributes to a short period of detection.
4. Conclusion
The validated method proved to be fast and sensitive,
allowing the quantification of low concentrations of ethanol,
diethyl ether, dichloromethane, chloroform, ethyl acetate,
and n-butanol as well as the qualitative identification of
chloroethane, n-propanol, toluene, xylene, and chlorofluo-
rocarbons. The HS technique associated with GC/MS allows
an unequivocal analysis of analytes, showing advantages in
multianalytical analyses such as the case of inhalants of
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Table 4: Intra- and interday accuracy and precision by GC/MS.
QC sample (𝑛 = 5) Intraday Interday
Accuracy (%) RSD (%) Accuracy (%) RSD (%)
Ethanol
LLOQ 3.4 10.2 6.7 5.0
LQC 7.4 −4.5 3.0 −2.0
MQC 5.5 −5.8 5.3 −0.7
HQC 9.2 −1.9 6.1 2.5
DQC 8.6 −9.6 11.6 0.4
Diethyl ether
LLOQ 7.3 −12.3 7.4 −5.0
LQC 5.1 −14 8.1 −6.6
MQC 9.2 −3.8 11.9 −1.1
HQC 13.0 −1.8 7.0 2.6
DQC 13.6 0.1 5.0 0.6
Dichloromethane
LLOQ 8.9 −7.6 11.1 −10.0
LQC 10.7 4.9 13.7 −8.3
MQC 7.2 −6.2 10.7 −3.3
HQC 12.2 −2.4 9.7 −2.3
DQC 13.1 −2.7 6.1 −0.6
Chloroform
LLOQ 7.9 −6.7 7.4 −5.0
LQC 9.6 −10.1 4.0 −12.5
MQC 10.6 −11.3 8.2 −7.2
HQC 13.8 −6.3 6.5 −1.3
DQC 13.5 −4.9 2.3 −2.6
Ethyl acetate
LLOQ 8.3 −6.9 14.1 6.6
LQC 5.3 −1.7 5.0 0.4
MQC 7.7 −7.9 4.8 −12.7
HQC 5.9 −3.4 9.7 −12.1
DQC 4.9 −9.3 3.9 −12.0
n-Butanol
LLOQ 3.3 4.9 7.7 10.0
LQC 5.7 −4.4 2.9 −2.3
MQC 5.0 −4.8 3.7 −1.4
HQC 8.8 −1.4 0.4 −1.5
DQC 0.9 −10.8 6.8 −3.5
RSD: relative standard deviation, LQC: low quality control, MQC: middle quality control, HQC: high quality control, and DQC: dilution quality control.
abuse. OF proved to be a promising biological matrix in the
toxicological analysis of inhalants, and the use of Quantisal
buffer was adequate for the analysis. The method developed
may be used to monitor the abuse of inhalants in routine
forensic and clinical analysis.
Competing Interests
The authors declare that they have no competing interests
regarding the publication of this paper.
Acknowledgments
The authors thank CNPq and FAPERGS for financial sup-
port and scholarships. The authors would like to thank
the CPAD/HCPA personnel involved in the collection of
samples, all volunteers, and Immunalysis Corporation for
the donation of Quantisal OF collection devices, filters, and
preservative buffer solution.
References
[1] Committee on Substance Abuse and Committee on Native
American Child Health, “Inhalant abuse,” Pediatrics, vol. 97, pp.
420–423, 1996.
[2] L. Baydala, “Canadian Paediatric Society First Nations, Inuit
and Métis Health Committee inhalants abuse,” Paediatrics and
Child Health, vol. 15, pp. 443–448, 2010.
[3] J. F. Williams, M. Storck, Committee on Substance Abuse, and
Committee onNative AmericanChildHealth, “Inhalant abuse,”
Pediatrics, vol. 119, no. 5, pp. 1009–1017, 2007.
[4] R. L. Balster, S. L. Cruz, M. O. Howard, C. A. Dell, and L. B.
Cottler, “Classification of abused inhalants,” Addiction, vol. 104,
no. 6, pp. 878–882, 2009.
[5] S. H. Dinwiddie, “Abuse of inhalants: a review,” Addiction, vol.
89, no. 8, pp. 925–939, 1994.
[6] M. F.M. Pedrozo andM.G. S. Jesus, “Inalantes,” inFundamentos
de Toxicologia, S. Oga, M. M. A. Camargo, and J. A. Batistuzzo,
Eds., Editora Atheneu, São Paulo, Brazil, 2008.
8 International Journal of Analytical Chemistry
[7] Presidência da República. Secretaria Nacional de Poĺıticas sobre
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